Miguel A. Martínez-González , Francisco J. Planes , Miguel Ruiz-Canela , Estefanía Toledo , Ramón Estruch , Jordi Salas-Salvadó , Rafael Valdés-Más , Pedro Mena , Olga Castañer , Montse Fitó , Clary Clish , Rikard Landberg , Clemens Wittenbecher , Liming Liang , Marta Guasch-Ferré , Rosa M. Lamuela-Raventós , Dong D. Wang , Nita Forouhi , Cristina Razquin , Frank B. Hu
{"title":"精准营养和心脏代谢疾病方面的进展","authors":"Miguel A. Martínez-González , Francisco J. Planes , Miguel Ruiz-Canela , Estefanía Toledo , Ramón Estruch , Jordi Salas-Salvadó , Rafael Valdés-Más , Pedro Mena , Olga Castañer , Montse Fitó , Clary Clish , Rikard Landberg , Clemens Wittenbecher , Liming Liang , Marta Guasch-Ferré , Rosa M. Lamuela-Raventós , Dong D. Wang , Nita Forouhi , Cristina Razquin , Frank B. Hu","doi":"10.1016/j.recesp.2024.09.005","DOIUrl":null,"url":null,"abstract":"<div><div>A growing body of research on nutrition omics has led to recent advances in cardiovascular disease epidemiology and prevention. Within the PREDIMED trial, significant associations between diet-related metabolites and cardiovascular disease were identified, which were subsequently replicated in independent cohorts. Some notable metabolites identified include plasma levels of ceramides, acyl-carnitines, branched-chain amino acids, tryptophan, urea cycle pathways, and the lipidome. These metabolites and their related pathways have been associated with incidence of both cardiovascular disease and type 2 diabetes. Future directions in precision nutrition research include: <em>a)</em> developing more robust multimetabolomic scores to predict long-term risk of cardiovascular disease and mortality; <em>b)</em> incorporating more diverse populations and a broader range of dietary patterns; and <em>c)</em> conducting more translational research to bridge the gap between precision nutrition studies and clinical applications.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 3","pages":"Pages 263-271"},"PeriodicalIF":5.9000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Avances en nutrición de precisión y enfermedades cardiometabólicas\",\"authors\":\"Miguel A. Martínez-González , Francisco J. Planes , Miguel Ruiz-Canela , Estefanía Toledo , Ramón Estruch , Jordi Salas-Salvadó , Rafael Valdés-Más , Pedro Mena , Olga Castañer , Montse Fitó , Clary Clish , Rikard Landberg , Clemens Wittenbecher , Liming Liang , Marta Guasch-Ferré , Rosa M. Lamuela-Raventós , Dong D. Wang , Nita Forouhi , Cristina Razquin , Frank B. Hu\",\"doi\":\"10.1016/j.recesp.2024.09.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>A growing body of research on nutrition omics has led to recent advances in cardiovascular disease epidemiology and prevention. Within the PREDIMED trial, significant associations between diet-related metabolites and cardiovascular disease were identified, which were subsequently replicated in independent cohorts. Some notable metabolites identified include plasma levels of ceramides, acyl-carnitines, branched-chain amino acids, tryptophan, urea cycle pathways, and the lipidome. These metabolites and their related pathways have been associated with incidence of both cardiovascular disease and type 2 diabetes. Future directions in precision nutrition research include: <em>a)</em> developing more robust multimetabolomic scores to predict long-term risk of cardiovascular disease and mortality; <em>b)</em> incorporating more diverse populations and a broader range of dietary patterns; and <em>c)</em> conducting more translational research to bridge the gap between precision nutrition studies and clinical applications.</div></div>\",\"PeriodicalId\":21299,\"journal\":{\"name\":\"Revista espanola de cardiologia\",\"volume\":\"78 3\",\"pages\":\"Pages 263-271\"},\"PeriodicalIF\":5.9000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista espanola de cardiologia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0300893224003889\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista espanola de cardiologia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0300893224003889","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
Avances en nutrición de precisión y enfermedades cardiometabólicas
A growing body of research on nutrition omics has led to recent advances in cardiovascular disease epidemiology and prevention. Within the PREDIMED trial, significant associations between diet-related metabolites and cardiovascular disease were identified, which were subsequently replicated in independent cohorts. Some notable metabolites identified include plasma levels of ceramides, acyl-carnitines, branched-chain amino acids, tryptophan, urea cycle pathways, and the lipidome. These metabolites and their related pathways have been associated with incidence of both cardiovascular disease and type 2 diabetes. Future directions in precision nutrition research include: a) developing more robust multimetabolomic scores to predict long-term risk of cardiovascular disease and mortality; b) incorporating more diverse populations and a broader range of dietary patterns; and c) conducting more translational research to bridge the gap between precision nutrition studies and clinical applications.
期刊介绍:
Revista Española de Cardiología, Revista bilingüe científica internacional, dedicada a las enfermedades cardiovasculares, es la publicación oficial de la Sociedad Española de Cardiología.